This site is intended for members of the public, patients and their carers in the UK. The Myeloma Insights Panel has been initiated, developed and funded by Pfizer Ltd.
A panel designed for patients, by the patient community
The Myeloma Insights Panel aims to improve key aspects of non-clinical patient care and the lives of people affected by this type of blood cancer. Whether you’ve been diagnosed with myeloma, or somebody close to you has, your feedback and involvement will help to ensure we are acting on the most important issues.
Pfizer is currently supporting numerous patient initiatives in the UK and we seek your input to make a positive change. Patients are at the heart of everything we do and your insights are invaluable to the Myeloma Insights Panel as they’re coming from the voice that matters the most.
If your life has been affected by myeloma, you have experienced first hand where change is needed. Patients have taught us that we need to work together and act on your insights in order to help shape and transform the healthcare system in the UK.
We are looking for people who...
You will be asked to
In return for your time
The applicaiton window is currently closed. Please continue to check back for further updates
PP-UNP-GBR-3619 May 2023
Copyright @ 2023 Pfizer Ltd. All rights reserved. PP-UNP-GBR-3617 April 2023
This website is brought to you by Pfizer Limited, a company registered in England and Wales under No.526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ,
VAT registration number GB201048427